PredxBio, Inc. is an artificial intelligence-driven, tissue-based biomarker company located in Pittsburgh, Pennsylvania. The firm specializes in tissue intelligence to support drug development decisions and improve survival curves in immunotherapy cancer treatments.
Subscribe to see PredxBio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PredxBio, Inc. is a company headquartered in United States. It has raised at least $1.2M across the 2 funding rounds on record. Its most recent funding round raised $601,321 in August 2023. Xcout tracks 8 named people at PredxBio, Inc., including B. Dusty Majumdar (CHIEF EXECUTIVE OFFICER).
2 more named people on record for PredxBio, Inc., with roles, board committees and tenure — see the full roster →
At least $1.2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $601,321 | — | |
| Seed | $601,321 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of PredxBio, Inc.'s closest competitors — see the full list of competitors and alternatives →
Deep Rx Inc. is a predictive analytics and healthcare technology company headquartered in Pittsburgh, Pennsylvania. The company advances AI-driven solutions for precision medicine, including developing COLOXIS, an artificial intelligence-powered chemotherapy drug-selection tool.
PreciseDx, Inc. provides an AI-powered platform called OncoIntelligence and its specific product, PreciseBreast, to analyze tissue samples and determine breast cancer recurrence risk. The company serves oncologists, surgeons, pathologists, payors, and patients by offering objective risk stratification and phenotype insights within hours.
Predix develops investigational deep learning software intended for medical image analysis in radiology and pathology, specifically for tumor and multi-cancer detection. The cloud-enabled system uses artificial intelligence to help radiologists and pathologists prioritize studies, highlight regions of interest, and support evaluations while meeting Canadian healthcare data standards.
Xlue Inc. is an artificial intelligence company based in Pittsburgh, Pennsylvania, building a health world model for general clinical intelligence and training cancer prediction tools on patient medical records.
Pierogi Therapeutics, Inc is a biotechnology company located in Pittsburgh, Pennsylvania, focusing on AI and machine learning applications in therapeutics.
Paige.AI, Inc. provides AI technology and services for digital pathology to improve cancer diagnosis and patient care. Headquartered in New York City, the company develops computational pathology products that assist medical professionals and healthcare institutions. Its platform leverages machine learning to analyze clinical slides and advance pathology research.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.